B Medical Systems to invest Rs 100 cr. to manufacture medical cold chain equipment in Gujarat
An MoU was signed between B Medical Systems and Gujarat government recently
An MoU was signed between B Medical Systems and Gujarat government recently
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus
CDSCO to fast-track trials and approval for COVID19 vaccine
The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.
The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.
The first six batches are being shipped to the Gamaleya Center, Moscow for the quality approval
The first batch will be shipped to the Gamaleya Center for the quality control
Targeted production of the dual vector Sputnik V for the first 12 months is 50 million doses from the date of start of commercial production
Financial support is being provided as a grant from the Government of India
Subscribe To Our Newsletter & Stay Updated